Cite
HARVARD Citation
Williams, D. et al. (2015). JAM‐A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV‐infected individuals. Journal of leukocyte biology. 97 (2), pp. 401-412. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Williams, D. et al. (2015). JAM‐A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV‐infected individuals. Journal of leukocyte biology. 97 (2), pp. 401-412. [Online].